Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes. 1993

B Dugas, and J C Renauld, and J Pène, and J Y Bonnefoy, and C Peti-Frère, and P Braquet, and J Bousquet, and J Van Snick, and J M Mencia-Huerta
INSERM/CJF 92-10, Hôpital Arnaud de Villeneuve, Montpellier, France.

IgE production by normal peripheral blood lymphocytes (PBL) is known to be triggered upon stimulation by interleukin (IL)-4. In the present study we showed that IL-9, another T cell-derived cytokine, markedly potentiated IgE production induced by suboptimal doses of IL-4, whereas no effect of IL-9 was observed in the absence of IL-4. The potentiating effect of IL-9 appeared to be associated with the increased frequency of IgE-producing cells, as revealed by a specific ELISA-spot assay. Under the same experimental conditions, IL-9 also enhanced the IL-4-induced IgG production but did not elicit IgM production. However, IL-9 did not amplify the IL-4-dependent expression of membrane-bound and soluble low affinity receptor for IgE (CD23). IL-4-induced IgE production was also potentiated by IL-6 but not by tumor necrosis factor-alpha and IL-1 beta. The possibility that the activity of IL-9 was mediated by IL-6 released from accessory cells was excluded by the observations that monocyte depletion did not abolish the effect of IL-9 and that IL-9 was still active on fluorescence-assisted cell sorted CD20+ B lymphocytes co-cultured with irradiated murine EL4 cells. In addition, IL-9 was shown to potentiate the IL-4-induced IgG and IgM production by normal human B lymphocytes preactivated with Staphylococcus aureus Cowan strain. Taken together, these data suggest that IL-9 plays a regulatory role in the IL-4-dependent immunoglobulin production.

UI MeSH Term Description Entries
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D000944 Antigens, Differentiation, B-Lymphocyte Membrane antigens associated with maturation stages of B-lymphocytes, often expressed in tumors of B-cell origin. Antigens, Differentiation, B-Cell,B-Cell Differentiation Antigens,B-Lymphocyte Differentiation Antigens,Blast-2 Antigen, B-Cell,Differentiation Antigens, B-Cell,Differentiation Antigens, B-Lymphocyte,Leu Antigens, B-Lymphocyte,Plasma Cell Antigens PC-1,Antigens, Differentiation, B Lymphocyte,Antigens, Plasma Cell, PC-1,B-Cell Blast-2 Antigen,Antigen, B-Cell Blast-2,Antigens, B-Cell Differentiation,Antigens, B-Lymphocyte Differentiation,Antigens, B-Lymphocyte Leu,B Cell Blast 2 Antigen,B Cell Differentiation Antigens,B Lymphocyte Differentiation Antigens,B-Lymphocyte Leu Antigens,Blast 2 Antigen, B Cell,Differentiation Antigens, B Cell,Differentiation Antigens, B Lymphocyte,Leu Antigens, B Lymphocyte,Plasma Cell Antigens PC 1
D015703 Antigens, CD Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation. CD Antigen,Cluster of Differentiation Antigen,Cluster of Differentiation Marker,Differentiation Antigens, Leukocyte, Human,Leukocyte Differentiation Antigens, Human,Cluster of Differentiation Antigens,Cluster of Differentiation Markers,Antigen Cluster, Differentiation,Antigen, CD,CD Antigens,Differentiation Antigen Cluster,Differentiation Marker Cluster,Marker Cluster, Differentiation

Related Publications

B Dugas, and J C Renauld, and J Pène, and J Y Bonnefoy, and C Peti-Frère, and P Braquet, and J Bousquet, and J Van Snick, and J M Mencia-Huerta
May 1993, Immunology,
B Dugas, and J C Renauld, and J Pène, and J Y Bonnefoy, and C Peti-Frère, and P Braquet, and J Bousquet, and J Van Snick, and J M Mencia-Huerta
June 1988, European journal of immunology,
B Dugas, and J C Renauld, and J Pène, and J Y Bonnefoy, and C Peti-Frère, and P Braquet, and J Bousquet, and J Van Snick, and J M Mencia-Huerta
September 1998, The Journal of allergy and clinical immunology,
B Dugas, and J C Renauld, and J Pène, and J Y Bonnefoy, and C Peti-Frère, and P Braquet, and J Bousquet, and J Van Snick, and J M Mencia-Huerta
September 1988, Proceedings of the National Academy of Sciences of the United States of America,
B Dugas, and J C Renauld, and J Pène, and J Y Bonnefoy, and C Peti-Frère, and P Braquet, and J Bousquet, and J Van Snick, and J M Mencia-Huerta
October 1989, The Journal of experimental medicine,
B Dugas, and J C Renauld, and J Pène, and J Y Bonnefoy, and C Peti-Frère, and P Braquet, and J Bousquet, and J Van Snick, and J M Mencia-Huerta
July 1996, International archives of allergy and immunology,
B Dugas, and J C Renauld, and J Pène, and J Y Bonnefoy, and C Peti-Frère, and P Braquet, and J Bousquet, and J Van Snick, and J M Mencia-Huerta
June 1994, Cellular immunology,
B Dugas, and J C Renauld, and J Pène, and J Y Bonnefoy, and C Peti-Frère, and P Braquet, and J Bousquet, and J Van Snick, and J M Mencia-Huerta
January 2007, International archives of allergy and immunology,
B Dugas, and J C Renauld, and J Pène, and J Y Bonnefoy, and C Peti-Frère, and P Braquet, and J Bousquet, and J Van Snick, and J M Mencia-Huerta
February 1979, Clinical and experimental immunology,
B Dugas, and J C Renauld, and J Pène, and J Y Bonnefoy, and C Peti-Frère, and P Braquet, and J Bousquet, and J Van Snick, and J M Mencia-Huerta
September 1988, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!